Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A in frequent and chronic tension-type headache
2019-001385-16Phase 3Completed
- Sponsor
- Helse Nord-Trøndelag
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in tension-type headache (TTH) (2 arms), sponsored by Helse Nord-Trøndelag. Primary endpoint: Number of headache days per month. Started Sep 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
tension-type headache (TTH)
Beyond the preview
Go deeper on 2019-001385-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001385-16.